2 most recent filings and news items mentioning DVA. Updated every 60 seconds.
EarningsAug 4, 2026Neutral
DaVita reported Q2 2026 revenue of $3.55 billion and diluted EPS of $4.02, surpassing analyst expectations. The company repurchased shares and utilized fresh debt for liquidity management.
View filing at SEC.gov →
OfferingJun 8, 2026Positive
DaVita Inc. executed a ninth amendment to its credit agreement on June 8, 2026, adding $500 million in incremental Tranche B-2 term loans. The expansion provides additional liquidity for the healthcare company and maintains consistent terms with existing debt arrangements.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.